Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Saudi Arabia must ensure benefits of change are inclusive with the opening of the tourism sector

Following the news (Friday 27 September) that Saudi Arabia has introduced reforms to its visa regulations and dress-code restrictions for women to encourage foreign tourists; Richard Thompson, Editorial Director at GlobalData, a leading data and analytics company, offers his view on Saudi Arabia’s tourism market: “The opening up of Saudi Arabia’s tourism market to international visitors […]
Read more

Potential first-in-class CMV therapeutic TAK-620 set to reach global sales of $7.1m by 2027

Following the publication (Wednesday 25 September) of new Phase II data for Takeda’s TAK-620 (maribavir) as treatment for cytomegalovirus (CMV) infections in recipients of hematopoietic cell or solid organ transplant; Paul Jeng, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his perspective: “TAK-620 performed favorably in virus clearance compared to the […]
Read more

Thomas Cook collapse down to failure to understand its own industry

Following the recent news (Monday 23 September) that Britain’s oldest travel agent has collapsed; Cyrus Mewawalla, Head of Thematic Research at GlobalData, a leading data and analytics company, offers his view on what caused the travel company’s demise: “Travel company Thomas Cook’s collapse is a direct result of the company’s failure to understand the disruptive […]
Read more

Thomas Cook may continue to struggle as it faces fierce travel sales competition online with UK market value set to grow 8.4% by 2021

Following today’s news (Friday 20 September) that Thomas Cook confirms its banks have ordered it to find an additional £200m after the troubled tour operator shares plunge 20%; Johanna Bonhill-Smith, Travel and Tourism Analyst at GlobalData, a leading data and analytics company, offers her view on the firm’s current crisis; “Thomas Cook’s current woes are […]
Read more

Biotronik sets high expectations for MDR certification among European medical device manufacturers

Following the recent news (Wednesday 18 September) that Biotronik has obtained European Medical Device Regulation (MDR) certification for a Class III (highest risk) medical device; Ashley Young, PhD, Medical Analyst at GlobalData, a leading data and analytics company, offers her view on the implications of this certification: “Biotronik becoming the first medical device manufacturer to […]
Read more

First peanut allergy therapy to receive backing from US regulators unlikely to be a good choice for all patients

Following the recent news that a US Food and Drug Administration (FDA) advisory panel recommended approving the first therapy for peanut allergies; Rose Joachim, Immunology Analyst at GlobalData, a leading data and analytics company, offers her view on the therapy’s future: “The FDA’s Allergenic Products Advisory Committee gave Palforzia a resounding vote of confidence and […]
Read more

Burgeoning oncology pipeline increases demand for containment manufacturing, good news for dedicated CMOs investing in containment facilities

The burgeoning oncology pipeline is particularly good news for AMRI, Apeloa, Cambrex, Lonza and Patheon which have multiple containment facilities, according to GlobalData, a leading data and analytics company. There were a total of 1,754 small molecule active pharmaceutical ingredient (API) contract manufacturing facilities included in PharmSource’s API report’s analysis with 29% offering containment capability, […]
Read more

59% of millennials globally find autonomous delivery appealing

Millennials worldwide are ready to try autonomous delivery, with 59% of consumers finding the concept either very or somewhat appealing, but boomers and the silent generation are yet to be convinced, according to research in 2018 Q3 conducted by GlobalData, a leading data and analytics company. GlobalData’s report, ‘ForeSights: Food Delivery by Drones’, highlighted that drones […]
Read more

Promising novel treatment Brineura set to reach global sales of $358m by 2025

Following the news (Thursday 12 September) that BioMarin’s Brineura (cerliponase alfa) received recommendation by NICE’s Highly Specialised Technology committee; Kajal Jaddoo, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on the drug’s potential: “Brineura has the potential to be commercially successful as currently there is no cure or life-extending treatments for neuronal […]
Read more
1 … 8 9 10 11 12 … 61